As of November 6, 2026, one holder's latest Schedule 13D or 13G filing report owning 5% or more of Davion Healthcare Plc. The largest reported stake is Jack Harry Kaye's, at 41.08%. 2 filings are on record since April 17, 2026 (Schedule 13D/A, August 11, 2026).
Sell to companies like Davion Healthcare Plc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Davion Healthcare Plc has 2 Schedule 13D or 13G filings on record since 2026-04-17. 1 holder's latest filing reports 5% or more of ordinary shares of (euro)0.01 par value per share. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| 41.08% | 10,268,948 | SCHEDULE 13D/A, 2026-08-11 | 2026-08-11 |
Holding shares or following this stake? See who's behind Davion Healthcare Plc and the warning signs.
Free to see. No signup.
Keep reading
More on Davion Healthcare Plc and the records around it.
Davion Healthcare Plc elsewhere on the record
- Form D filing Sep 2026
- Who owns it
Watch Davion Healthcare Plc
Get an email when Davion Healthcare Plc files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Davion Healthcare Plc?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Davion Healthcare Plc: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Davion Healthcare Plc covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
3 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Voting and dispositive power, as filed
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| Jack Harry Kaye | 10,268,948 | 0 | 10,268,948 | 0 | SCHEDULE 13D/A, 2026-08-11 |
| Rallinson Corp | 0 | 0 | 0 | 0 | SCHEDULE 13D/A, 2026-08-11 |
| Rallinson Ltd | 0 | 0 | 0 | 0 | SCHEDULE 13D/A, 2026-08-11 |
The latest filing identifies Davion Healthcare Plc by CUSIP G2779R101 and gives its principal executive office as Unit A, West Cork Business & Technology Park, Clonakilty, County Cork (SCHEDULE 13D/A, 2026-08-11).
Source of funds (Item 3)
No funds or other consideration were paid or received in connection with the transfers described in this Amendment No. 1. On August 11, 2026, Rallinson Corp transferred 1,245,000 Ordinary Shares to Jack Harry Kaye, and Rallinson Ltd transferred 3,860,530 Ordinary Shares to Jack Harry Kaye. Mr. Kaye was the ultimate beneficial owner of such Ordinary Shares immediately before the transfers and remained the beneficial owner immediately following the transfers. Accordingly, the transfers did not involve the expenditure of funds by Mr.Jack Harry Kaye, SCHEDULE 13D/A, 2026-08-11
Purpose of Transaction (Item 4)
Jack Harry Kaye
On August 11, 2026, Rallinson Corp transferred 1,245,000 Ordinary Shares of the Issuer to Jack Harry Kaye for no consideration, and Rallinson Ltd transferred 3,860,530 Ordinary Shares of the Issuer to Mr. Kaye for no consideration. Mr. Kaye is the sole director, sole shareholder and ultimate beneficial owner of Rallinson Corp and Rallinson Ltd and was the beneficial owner of the Ordinary Shares held through those entities immediately prior to the transfers. The transfers were undertaken solely for the purpose of consolidating Mr. Kaye's holdings of Ordinary Shares into his personal name and converting the manner in which such shares are held from indirect ownership through Rallinson Corp and Rallinson Ltd to direct ownership by Mr. Kaye. No Ordinary Shares were purchased from or sold to any third party in connection with the transfers, no consideration was paid or received, and the transfers did not result in any change in Mr. Kaye's aggregate beneficial ownership or pecuniary interest in the Ordinary Shares. Immediately prior to the transfers, Mr. Kaye beneficially owned an aggregate of 10,268,948 Ordinary Shares, consisting of: (a) 5,163,418 Ordinary Shares held directly by Mr. Kaye; (b) 1,245,000 Ordinary Shares held through Rallinson Corp; and (c) 3,860,530 Ordinary Shares held through Rallinson Ltd. Immediately following completion of the transfers, Mr. Kaye continued to beneficially own the same aggregate 10,268,948 Ordinary Shares, all of which are held …The first part of Item 4 of the SCHEDULE 13D/A filed 2026-08-11; the filing has the rest
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2026-04-17 | Jack Harry Kaye | 20.64% | SCHEDULE 13D |
| 2026-08-11 | Jack Harry Kaye | 41.08% | SCHEDULE 13D/A |
Questions about who owns Davion Healthcare Plc
Who owns Davion Healthcare Plc?
On this page, one holder's latest ownership filing reports 5% or more of Davion Healthcare Plc: Jack Harry Kaye (41.08%, Schedule 13D/A, filed 2026-08-11).
When did Jack Harry Kaye buy into Davion Healthcare Plc?
The filings give report dates, not purchase dates. The earliest filing from Jack Harry Kaye on this page is the Schedule 13D, filed 2026-04-17, reporting 20.64%; its latest, Schedule 13D/A filed 2026-08-11, reports 41.08%.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 2 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Also on the record for Davion Healthcare Plc
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| September 8, 2026 | Form D, private offering | $350K sold | Form D page | Source |
Tools for this story
Each opens in a new tab, filled in for Davion Healthcare Plc. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.